Perfluorocarbons enhance a T 2 *-based MRI technique for identifying the penumbra in a rat model of acute ischemic stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 9, 2013, Pages 1422-1428

  Deuchar, Graeme A ^a   Brennan, David ^b   Griffiths, Hugh ^b   MacRae, Imhairi ^a   Santosh, Celestine ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

acute stroke; BOLD contrast; brain imaging; focal ischemia; MRI

Indexed keywords

DEOXYHEMOGLOBIN; OXYGEN; PERFLUORODECALIN; BLOOD SUBSTITUTE; CONTRAST MEDIUM; FLUOROCARBON; HEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOLD SIGNAL; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN PERFUSION; BRAIN REGION; BRAIN TISSUE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; EMULSION; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; IMAGE ENHANCEMENT; INHALATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RAT; REPERFUSION; SENSITIVITY ANALYSIS; STROKE PATIENT; ANIMAL; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; HUMAN; METABOLISM; METHODOLOGY; RADIOGRAPHY; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD SUBSTITUTES; BRAIN ISCHEMIA; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FLUOROCARBONS; HEMOGLOBINS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; STROKE;

EID: 84883741865     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.86     Document Type: Article

References (40)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
2. Furlan M, Marchal G, Viader F, Derlon JM, Baron JC. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 1996; 40: 216-226. (Pubitemid 26274557)
3. Perez A, Restrepo L, Kleinman JT, Barker P, Beauchamp N, Wityk RJ. Patients with diffusion-perfusion mismatch on magnetic resonance imaging 48 hours or more after stroke symptom onset: clinical and imaging features. J Neuroimaging 2006; 16: 329-333. (Pubitemid 44521383)
4. Ahmed N, Wahlgren N, Grond M, Hennerici M, Lees KR, Mikulik R et al. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol 2010; 9: 866-874.
5. Saver JL, Smith EE, Fonarow GC, Reeves MJ, Zhao X, Olson DM et al. The "Golden Hour" and acute brain ischemia: presenting features and lytic therapy in 430,000 patients arriving within 60 minutes of stroke onset. Stroke 2010; 41: 1431-1439.
6. Rudd AG, Hoffman A, Grant R, Campbell JT, Lowe D. Stroke thrombolysis in England, Wales and Nothern Ireland: how much do we do and how much do we need? J Neurol Neurosurg Psychiatry 2011; 82: 14-19.
7. Moradiya Y, Janjua N. Presentation and outcomes of "Wake-Up Strokes" in a large randomized stroke trial: analysis of data from the international stroke trial. J Stroke Cerebrovasc Dis 2012; PMID: 22939198 (in press).
8. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-1025.
9. Hill MD, Barber PA, Takahashi J, Demchuk AM, Feasby TE, Buchan AM. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. CMAJ 2000; 162: 1281-1284. (Pubitemid 30304328)
10. Baron JC. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis 1999; 9: 193-201.
11. Schlaug G, Benfield A, Baird AE, Siewert B, Lö vblad KO, Parker RA et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology 1999; 53: 1528-1537. (Pubitemid 29491949)
12. Heiss WD, Sobesky J. Comparison of PET and DWI/PWI-MRI in acute ischemic stroke. Keio J Med 2008; 57: 125-131.
13. Coutts SB, Simon JE, Tomanek AI, Barber PA, Chan J, Hudon ME et al. Reliability of assessing percentage of diffusion-perfusion mismatch. Stroke 2003; 34: 1681-1683. (Pubitemid 36842626)
14. Butcher KS, Parsons M, MacGregor L, Barber PA, Chalk J, Bladin C et al. EPITHET investigators. Refining the perfusion-diffusion mismatch hypothesis. Stroke 2005; 36: 1153-1159. (Pubitemid 40798731)
15. Olivot JM, Mlynash M, Thijs VN, Purushotham A, Kemp S, Lansberg MG et al. Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR. Stroke 2009; 40: 1692-1697.
16. Kranz PG, Eastwood JD. Does diffusion-weighted imaging represent the ischemic core? An evidence-based systematic review. AJNR, Am J Neuroradiol 2009; 30: 1206-1212.
17. Nagakane Y, Christensen S, Brekenfeld C, Henry MA, Churilov L, Parsons MW et al. EPITHET: Positive result after reanalysis using baseline diffusion-weighted imaging/perfusion-weighted imaging co-registration. Stroke 2011; 42: 59-64.
18. Labeyrie MA, Turc G, Hess A, Hervo P, Mas JL, Meder JF et al. Diffusion lesion reversal after thrombolysis: a MR correlate of early neurological improvement. Stroke 2012; 43: 2986-2991.
19. Campbell BC, Purushotham A, Christensen S, Desmond PM, Nagakane Y, Parsons MW et al. EPITHET-DEFUSE investigators. J Cereb Blood Flow Metab 2012; 32: 50-56.
20. Santosh C, Brennan D, McCabe C, Macrae IM, Holmes WM, Graham DI et al. Potential use of oxygen as a metabolic biosensor in combination with T2*-weighted MRI to define the ischemic penumbra. J Cereb Blood Flow Metab 2008; 28: 1742-1753.
21. Ogawa S, Lee TM, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci USA 1990; 87: 9868-9872. (Pubitemid 120016545)
22. Pauling L, Coryell CD. The magnetic properties and structure of hemoglobin, oxyhemoglobin and carbonmonoxyhemoglobin. Proc Natl Acad Sci USA 1936; 22: 210-216.
23. Robertson CA, McCabe C, Gallagher L, Lopez-Gonzalez Mdel R, Holmes WM, Condon B et al. Stroke penumbra defined by an MRI-based oxygen challenge technique: 1. Validation using [14C]2-deoxyglucose autoradiography. J Cereb Blood Flow Metab 2011; 31: 1778-1787.
24. Robertson CA, McCabe C, Gallagher L, Lopez-Gonzalez Mdel R, Holmes WM, Condon B et al. Stroke penumbra defined by an MRI-based oxygen challenge technique: 2. Validation based on the consequences of reperfusion. J Cereb Blood Flow Metab 2011; 31: 1788-1798.
25. Dani KA, Santosh C, Brennan D, McCabe C, Holmes WM, Condon B et al. T2*-weighted magnetic resonance imaging with hyperoxia in acute ischemic stroke. Ann Neurol 2010; 68: 37-47.
26. Pilkinton DT, Gaddam SR, Reddy R. Characterization of paramagnetic effects of molecular oxygen on blood oxygenation level-dependent-modulated hyperoxic contrast studies of the human brain. Magn Reson Med 2011; 66: 794-801.
27. Baskerville TA, Deuchar GA, McCabe C, Robertson CA, Holmes WM, Santosh C et al. Influence of 100% and 40% oxygen on penumbral blood flow, oxygen level, and T2*-weighted MRI in a rat stroke model. J Cereb Blood Flow Metab 2011; 31: 1799-1806.
28. Jensen-Kondering U, Baron JC. Oxygen imaging by MRI: can blood oxygen leveldependent imaging depict the ischemic penumbra? Stroke 2012; 43: 2264-2269.
29. Law R, Bukwirwa H. The physiology of oxygen delivery. Update Anaesth 1999; 10: 1-2.
30. Clark Jr LC, Becattini F, Kaplan S. The physiological effects artificial blood made from inert organic oxygen solvents. Ala J Med Sci 1972; 9: 16-29.
31. Moffat BA, Chenevert TL, Hall DE, Rehemtulla A, Ross BD. Continuous arterial spin labeling using a train of adiabatic inversion pulses. J Magn Reson Imaging 2005; 21: 290-296. (Pubitemid 40280124)
32. Lo EH, Pierce AR, Mandeville JB, Rosen BR. Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships. Stroke 1997; 28: 439-446; discussion 446-447.
33. Meng X, Fisher M, Shen Q, Sotak CH, Duong TQ. Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia. Ann Neurol 2004; 55: 207-212. (Pubitemid 38166997)
34. Shen Q, Huang S, Du F, Duong TQ. Probing ischemic tissue fate with BOLD fMRI of brief oxygen challenge. Brain Res 2011; 1425: 132-141.
35. Daugherty WP, Levasseur JE, Sun D, Spiess BD, Bullock MR. Perfluorocarbon emulsion improves cerebral oxygenation and mitochondrial function after fluid percussion brain injury in rats. Neurosurgery 2004; 54: 1223-1230; discussion 1230. (Pubitemid 38585938)
36. Kwon TH, Sun D, Daugherty WP, Spiess BD, Bullock MR. Effect of perfluorocarbons on brain oxygenation and ischemic damage in an acute subdural hematoma model in rats. J Neurosurg 2005; 103: 724-730. (Pubitemid 43193881)
37. Liu S, Shi H, Liu W, Furuichi T, Timmins GS, Liu KJ. Interstitial pO2 in ischemic penumbra and core are differentially affected following transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2004; 24: 343-349. (Pubitemid 38314590)
38. Cartheuser CF. Standard and pH-affected hemoglobin-O2 binding curves of Sprague-Dawley rats under normal and shifted P50 conditions. Comp Biochem Physiol Comp Physiol 1993; 106: 775-782.
39. Prielmeier F, Nagatomo Y, Frahm J. Cerebral blood oxygenation in rat brain during hypoxic hypoxia. Quantitative MRI of effective transverse relaxation rates. Magn Reson Med 1994; 31: 678-681. (Pubitemid 24166823)
40. Lin W, Paczynski RP, Celik A, Kuppusamy K, Hsu CY, Powers WJ. Experimental hypoxemic hypoxia: changes in R2*of brain parenchyma accurately reflect the combined effects of changes in arterial and cerebral venous oxygen saturation. Magn Reson Med 1998; 39: 474-481. (Pubitemid 28128391)